Caring for patients runs in our DNA, say Cipla's Samina Hamied, Umang Vohra

'Cipla has so many capabilities that for anything we need to do, we say we can do it'

Umang Vohra, Samina Hamied, Cipla

Umang Vohra, MD & Global CEO, Cipla and Samina Hamied, Executive Vice-chairperson, Cipla | Photo: Kamlesh Pednekar

Cipla was at the forefront of the pharmaceutical industry’s response to the Covid-19 pandemic, whether by tying up with MNCs for products like remdesivir or tocilizumab, or ramping up production

Also Read

Hospital admissions under Ayushman Bharat double in the last 6 months

BS Awards for Corporate Excellence 2021: Samina Hamied lauds team effort

Sun Pharma Q3 results: Net profit rises 11% to Rs 2,058.8 crore

Reforming provider payments, price setting for Ayushman Bharat

Strong specialty sales and volumes keep it sunny for Sun Pharma

Aatmanirbhar Bharat needs Aatmanirbhar banking sector: CII's Sanjiv Bajaj

Keen to invest more in Indian software, fintech: Insight Partners top brass

We aren't giving out data continuum of the user: Amagi's Baskar Subramanian

Slowdown, earnings pressure are temporary: Dalmia Cement (Bharat) MD & CEO

India can't be scoffed at by global chipmakers: Ather Energy's Tarun Mehta

First Published: May 19 2022 | 6:04 AM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on are available only to BS Premium subscribers.

Register to